• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi, Jan. 11

The Union Cabinet today forwarded the draft pharmaceutical policy to a Group of Ministers (GoM) for further consideration. The policy, which along with other measures seeks to bring essential medicines under price control, was strongly opposed by the industry. "A GoM will be appointed to look into the entire aspect and it will come back to the Cabinet shortly. The policy is expected to come up in the next Parliamentary session - the Budget session," said Mr P.R. Dasmunsi, Minister of Information and Broadcasting and Parliamentary Affairs.

The Cabinet has approved of the setting up of a Central Drugs Authority of India as an autonomous organisation under the Ministry of Health and Family Welfare to be located at the Food and Drug Bhawan, New Delhi. It has also approved centralising the licensing of drug manufacturing units from the States to the Union Government. The transition is to occur in a phased manner over five years.

More Stories on : Pharmaceuticals | Policy

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
B.R. Shetty gets Pravasi award

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line